These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 19788237)

  • 1. Optimization of the antitumor efficacy of a synthetic mitochondrial toxin by increasing the residence time in the cytosol.
    Dilda PJ; Decollogne S; Weerakoon L; Norris MD; Haber M; Allen JD; Hogg PJ
    J Med Chem; 2009 Oct; 52(20):6209-16. PubMed ID: 19788237
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Para to ortho repositioning of the arsenical moiety of the angiogenesis inhibitor 4-(N-(S-glutathionylacetyl)amino)phenylarsenoxide results in a markedly increased cellular accumulation and antiproliferative activity.
    Dilda PJ; Decollogne S; Rossiter-Thornton M; Hogg PJ
    Cancer Res; 2005 Dec; 65(24):11729-34. PubMed ID: 16357185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Engineered apoptosis-inducing peptides with enhanced mitochondrial localization and potency.
    Horton KL; Kelley SO
    J Med Chem; 2009 May; 52(10):3293-9. PubMed ID: 19397319
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A selective mitochondrial-targeted chlorambucil with remarkable cytotoxicity in breast and pancreatic cancers.
    Millard M; Gallagher JD; Olenyuk BZ; Neamati N
    J Med Chem; 2013 Nov; 56(22):9170-9. PubMed ID: 24147900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism of selectivity of an angiogenesis inhibitor from screening a genome-wide set of Saccharomyces cerevisiae deletion strains.
    Dilda PJ; Don AS; Tanabe KM; Higgins VJ; Allen JD; Dawes IW; Hogg PJ
    J Natl Cancer Inst; 2005 Oct; 97(20):1539-47. PubMed ID: 16234568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential use of cetrimonium bromide as an apoptosis-promoting anticancer agent for head and neck cancer.
    Ito E; Yip KW; Katz D; Fonseca SB; Hedley DW; Chow S; Xu GW; Wood TE; Bastianutto C; Schimmer AD; Kelley SO; Liu FF
    Mol Pharmacol; 2009 Nov; 76(5):969-83. PubMed ID: 19654225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A peptide trivalent arsenical inhibits tumor angiogenesis by perturbing mitochondrial function in angiogenic endothelial cells.
    Don AS; Kisker O; Dilda P; Donoghue N; Zhao X; Decollogne S; Creighton B; Flynn E; Folkman J; Hogg PJ
    Cancer Cell; 2003 May; 3(5):497-509. PubMed ID: 12781367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anticancer activity and mechanisms of diacetyldianhydrogalactitol on hepatoma QGY-7703 cells.
    Zhang XY; Lian Yan X; Guo W; Xu B; Li M; Zhou Y; Rong Cui J
    Anticancer Drugs; 2009 Nov; 20(10):926-31. PubMed ID: 19741503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estrone derived steroidal diepoxide: biologically active compound and precursor of a stable steroidal A,B-spiro system.
    Milic D; Kop T; Csanadi J; Juranic Z; Zizak Z; Gasic MJ; Solaja B
    Steroids; 2009 Nov; 74(12):890-5. PubMed ID: 19538979
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery and potency optimization of 2-amino-5-arylmethyl-1,3-thiazole derivatives as potential therapeutic agents for prostate cancer.
    Krasavin M; Karapetian R; Konstantinov I; Gezentsvey Y; Bukhryakov K; Godovykh E; Soldatkina O; Lavrovsky Y; Sosnov AV; Gakh AA
    Arch Pharm (Weinheim); 2009 Jul; 342(7):420-7. PubMed ID: 19544302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo structural activity and optimization studies of folate-tubulysin conjugates.
    Reddy JA; Dorton R; Dawson A; Vetzel M; Parker N; Nicoson JS; Westrick E; Klein PJ; Wang Y; Vlahov IR; Leamon CP
    Mol Pharm; 2009; 6(5):1518-25. PubMed ID: 19630399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolism of the tumor angiogenesis inhibitor 4-(N-(S-Glutathionylacetyl)amino)phenylarsonous acid.
    Dilda PJ; Ramsay EE; Corti A; Pompella A; Hogg PJ
    J Biol Chem; 2008 Dec; 283(51):35428-34. PubMed ID: 18723877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure, enzymatic stability and antitumor activity of sea lamprey GnRH-III and its dimer derivatives.
    Mezo G; Czajlik A; Manea M; Jakab A; Farkas V; Majer Z; Vass E; Bodor A; Kapuvári B; Boldizsár M; Vincze B; Csuka O; Kovács M; Przybylski M; Perczel A; Hudecz F
    Peptides; 2007 Apr; 28(4):806-20. PubMed ID: 17254668
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-throughput cell-based screening of 4910 known drugs and drug-like small molecules identifies disulfiram as an inhibitor of prostate cancer cell growth.
    Iljin K; Ketola K; Vainio P; Halonen P; Kohonen P; Fey V; Grafström RC; Perälä M; Kallioniemi O
    Clin Cancer Res; 2009 Oct; 15(19):6070-8. PubMed ID: 19789329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Employing pancreatic tumor γ-glutamyltransferase for therapeutic delivery.
    Ramsay EE; Decollogne S; Joshi S; Corti A; Apte M; Pompella A; Hogg PJ; Dilda PJ
    Mol Pharm; 2014 May; 11(5):1500-11. PubMed ID: 24654974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 7-((4-Substituted)piperazin-1-yl) derivatives of ciprofloxacin: synthesis and in vitro biological evaluation as potential antitumor agents.
    Azéma J; Guidetti B; Dewelle J; Le Calve B; Mijatovic T; Korolyov A; Vaysse J; Malet-Martino M; Martino R; Kiss R
    Bioorg Med Chem; 2009 Aug; 17(15):5396-407. PubMed ID: 19595598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SC68896, a novel small molecule proteasome inhibitor, exerts antiglioma activity in vitro and in vivo.
    Roth P; Kissel M; Herrmann C; Eisele G; Leban J; Weller M; Schmidt F
    Clin Cancer Res; 2009 Nov; 15(21):6609-18. PubMed ID: 19825946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure-activity relationship studies of targeting ligands against breast cancer cells.
    Yao N; Xiao W; Meza L; Tseng H; Chuck M; Lam KS
    J Med Chem; 2009 Nov; 52(21):6744-51. PubMed ID: 19835381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Doxazosin-related alpha1-adrenoceptor antagonists with prostate antitumor activity.
    Giardinà D; Martarelli D; Sagratini G; Angeli P; Ballinari D; Gulini U; Melchiorre C; Poggesi E; Pompei P
    J Med Chem; 2009 Aug; 52(15):4951-4. PubMed ID: 19719240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A synthetic peptide mediated active targeting of cisplatin liposomes to Tie2 expressing cells.
    Mai J; Song S; Rui M; Liu D; Ding Q; Peng J; Xu Y
    J Control Release; 2009 Nov; 139(3):174-81. PubMed ID: 19576253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.